Navigation Links
A*STAR scientists discover novel hormone essential for heart development
Date:12/6/2013

1. Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids long, making it amongst the tiniest proteins made by the human body.

2. The team led by Dr Bruno Reversade carried out experiments to determine ELABELA's function, since its existence was hitherto unsuspected. Using zebrafish designed to specifically lack this hormone, they uncovered that ELABELA is indispensable for heart formation. Zebrafish embryos without this gene had rudimentary or no heart at all (see Figure 1). Their results were published in the 5 December 2013 online issue of Developmental Cell.

3. Deficiencies in hormones are the cause of many diseases, such as the loss of insulin or insulin resistance, that results in diabetes, and irregularities in appetite and satiety hormones that can cause obesity. Hormones are known to control functions such as sleep, appetite and fertility. However, this is the first time that scientists have revealed the existence of a conserved hormone playing such an early role during embryogenesis, effectively orchestrating the development of an entire organ.

4. The team also found that ELABELA uses a receptor previously believed to be specific to APELIN, a blood-pressure controlling hormone. This receptor called APJ or Apelin Receptor has dual functions - it first conveys signals from ELABELA and then from APELIN. Mutations in the Apelin Receptor also prevent the heart from forming. Zebrafish bereft of the Apelin Receptor are referred to as the Grinch, in reference to the cold and heartless cartoon character created by Dr. Seuss in 1957.

5. ELABELA has also been found to be expressed in human embryonic stem cells , indicating that it might have other functions beyond its
'/>"/>

Contact: Vithya Selvam
vithya_selvam@a-star.edu.sg
656-826-6291
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert  

Page: 1 2

Related biology news :

1. A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
2. A*STAR scientists solve century-old mystery by finding stable haploid strains of Candida albicans
3. A*STAR scientists discover potential drug for deadly brain cancer
4. Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
5. Scientists unearth secrets of Périgord truffles, the culinary black diamond
6. Top scientists to present at Epigenetic Control and Cellular Plasticity symposium
7. Salk scientists crack riddle of important drug target
8. Scientists stitch up photosynthetic megacomplex
9. Scripps Research Institute scientists achieve most detailed picture ever of key part of hepatitis C
10. UCLA research may help scientists understand what causes pregnancy complications
11. Scientists discover how leukemia cells exploit enhancer DNA elements to cause lethal disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A*STAR scientists discover novel hormone essential for heart development
(Date:4/1/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces the second shipment of ... to early access pre-order customers. Feedback ... outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop & ... at all outlets and very easy to use. Several ...
(Date:4/1/2015)... --  Medisafe ™, the leading global medication management platform ... and Android smartphones and tablets, announces today ... to allow patients to track and correlate their adherence ... will be able to visualize in real-time how taking ... as glucose levels and blood pressure. "Patients ...
(Date:3/31/2015)... 31, 2015  Elephant Talk Communications Corp. (NYSE MKT: ... of Software Defined Network Architecture (ET Software DNA® 2.0) ... of approximately $20.4 million for the year ended December ... for the year ended December 31, 2013. ... had completed its multi-year transition away from its legacy ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... to any process by which a cell converts one ... of signal transduction involve ordered sequences of biochemical reactions ... and activated by second messengers, resulting in a signal ... the order of milliseconds in the case of ion ...
... found the dose of DHA (docosahexaenoic acid) that is "just ... research report appearing in the September 2009 print issue of ... show that a 200 mg dose of DHA per day ... problems, such as those related to aging, atherosclerosis, and diabetes. ...
... Travelers to the neotropicsthe tropical lands of the Americasmight ... insects flittering over sunny puddles or among dense forest ... are moths that have reinvented themselves as butterflies, converging ... hairy relatives. Now, a new revision of the taxonomic ...
Cached Biology News:Moths cloaked in color 2Moths cloaked in color 3Moths cloaked in color 4
(Date:4/1/2015)... SAN DIEGO , April 1, 2015 /PRNewswire/ ... three-dimensional biology company focused on delivering breakthrough 3D ... vitro three-dimensional kidney tissue at the 2015 Experimental ... . "Kidney represents an ideal ... tissues that can be tremendously useful in pharmaceutical ...
(Date:4/1/2015)... and NEW YORK , ... (NASDAQ:  PTBI), a biopharmaceutical company advancing protein biologic ... an overview of the Company,s 2014 achievements and ... below demonstrate the progress the Company has made ... corporate partnerships for its MuGard programs, the FDA ...
(Date:4/1/2015)... Holomic is introducing the HRDR-400, the first ... fluorescent rapid tests with one device. , Holomic ... and is already selling its HRDR-200 chromatographic and HRDR-300 ... its kind offering for manufacturers and end-users that need ... Karlovac, CEO of Holomic LLC, commented, "We are responding ...
(Date:4/1/2015)... CITY and LONDON , April ... research reports and solutions, MarketResearch.com is pleased to highlight a ... a year of market growth and opportunity for the stem ... company or cord blood bank, competing in the stem cell ... predict industry trends, and act on market changes before the ...
Breaking Biology Technology:Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 3Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 5PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 6Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4
... -- 3SBio Inc.,(Nasdaq: SSRX ), a ... marketing biopharmaceutical products primarily,in China, today announced that ... Financial,Officer, effective February 1, 2009. Since joining 3SBio ... the financial advisor for the company, providing advice,on ...
... Ireland, February 9, Shire plc (LSE: SHP, NASDAQ: ... Notice letters from Barr Laboratories, Inc.,("Barr) and Mylan, Inc. ... each case of the filing of an Abbreviated New ... and 1gm FOSRENOL(R),(lanthanum carbonate). , ...
... Feb. 9 , , ... new Progen board , Call by ... Significant funding shortfall identified in the Progen merger ... Requisition , Late last week Progen Pharmaceuticals Limited (ASX: PGL) responded ...
Cached Biology Technology:3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer 2Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan 2Cytopia and Other Progen Shareholders Maintain Call for Meeting 2Cytopia and Other Progen Shareholders Maintain Call for Meeting 3Cytopia and Other Progen Shareholders Maintain Call for Meeting 4
...
Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
All-in-one mix, removes primers and dNTPs from PCR product for following direct sequencing...
Biology Products: